Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 14, 2022 (Week 19)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 149 448 4,719 2,993 6 13 116 71
New England 2 17 112 125 - 1 1 -
Connecticut - 6 29 35 - 0 - -
Maine 1 7 36 30 - 0 - -
Massachusetts - 9 - 36 - 0 - -
New Hampshire - 4 24 11 - 1 1 -
Rhode Island 1 4 15 9 - 1 - -
Vermont - 3 8 4 - 0 - -
Middle Atlantic 36 86 742 430 4 6 32 19
New Jersey 4 12 75 80 3 3 11 16
New York (excluding New York City) 16 46 277 117 1 3 14 3
New York City 7 22 172 119 - 6 - -
Pennsylvania 9 19 218 114 - 2 7 -
East North Central 12 92 888 442 - 4 33 9
Illinois N NC N N N NC N N
Indiana - 28 166 140 - 0 - -
Michigan 3 18 164 106 - 2 3 3
Ohio - 41 413 190 - 4 30 6
Wisconsin 9 19 145 6 - 0 - -
West North Central 4 32 302 160 - 2 9 18
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 1 20 199 102 - 2 9 10
Nebraska 2 7 44 25 - 0 - -
North Dakota 1 4 23 13 - 0 - -
South Dakota - 7 36 20 - 1 - 8
South Atlantic 19 73 550 536 1 5 9 5
Delaware 2 5 37 18 - 0 - -
District of Columbia - 2 9 8 - 0 - -
Florida 11 26 245 185 1 3 8 3
Georgia - 18 34 167 - 0 - -
Maryland 6 11 15 76 - 0 - 1
North Carolina N NC N N N NC N N
South Carolina - 25 181 1 - 3 1 1
Virginia - 2 5 6 - 0 - -
West Virginia - 11 24 75 - 0 - -
East South Central 18 43 421 322 - 2 2 2
Alabama 2 19 118 92 - 1 1 -
Kentucky 4 12 73 35 - 2 1 2
Mississippi 2 8 65 52 - 0 - -
Tennessee 10 26 165 143 - 0 - -
West South Central 9 120 531 350 1 4 12 14
Arkansas 4 10 83 47 - 1 1 -
Louisiana - 29 61 87 - 2 2 -
Oklahoma N NC N N N NC N N
Texas 5 110 387 216 1 4 9 14
Mountain 46 94 1,095 575 - 3 13 4
Arizona 22 48 505 250 - 1 2 2
Colorado 12 28 235 110 - 1 2 -
Idaho N NC N N N NC N N
Montana 1 5 33 20 - 1 - -
Nevada 1 10 101 70 - 1 1 1
New Mexico 5 16 139 58 - 0 - -
Utah 5 12 82 47 - 2 8 1
Wyoming - 3 - 20 - 0 - -
Pacific 3 12 78 53 - 2 5 -
Alaska 3 11 67 43 - 2 5 -
California N NC N N N NC N N
Hawaii - 3 11 10 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 149 448 4,719 2,994 6 13 116 71
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.